Literature DB >> 10878450

Functional expression of HGF and its receptor in human colorectal cancer.

J M Otte1, F Schmitz, K Kiehne, H U Stechele, T Banasiewicz, P Krokowicz, T Nakamura, U R Fölsch, K Herzig.   

Abstract

BACKGROUND: Hepatocyte growth factor (HGF) stimulates proliferation, migration and morphogenesis of epithelial cells by specific binding to its receptor c-met. Overexpression of HGF or c-met has been reported for human gastric or pancreatic cancer. In colorectal cancer overexpression of c-met but not HGF has been shown. However, elevated HGF serum levels have been detected in colorectal cancer patients. Therefore, the present study was performed to investigate expression patterns of both c-met and HGF in colorectal cancers and metastasis in comparison to normal mucosa. Furthermore, the mitogenic actions of HGF on colorectal cancer cells were studied in vitro.
METHODS: Expression of c-met and HGF were analyzed by RT-PCR and Western blotting and localized in the tissues utilizing immunohistochemistry. Mitogenic effects of HGF were determined in four human colon cancer cell lines by (3)H-thymidine incorporation studies.
RESULTS: C-met and HGF mRNA were detectable in 60% of the normal specimen, but in the majority of cancer samples, and in just 33% of the liver metastasis. In cancer samples a coexpression of c-met and HGF was detected in 77% of the specimens. The extent of protein expression of receptor and ligand correlated with the mRNA expression. Moreover, c-met protein expression was increased 2- to 3-fold in colorectal cancers. C-met was detected in cells of epithelial origin, whereas HGF was expressed by mesenchymal cells. In vitro, HGF significantly stimulated cell growth in all four cell lines.
CONCLUSION: Overexpression of c-met protein in colorectal cancers is combined with an expression of HGF in the majority of cases suggesting a paracrine manner of growth enhancement, while only a weak expression of c-met or HGF was detected in metastatic tissues. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878450     DOI: 10.1159/000007764

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  30 in total

1.  The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

Authors:  Luis J Herrera; Talal El-Hefnawy; Pierre E Queiroz de Oliveira; Siva Raja; Sydney Finkelstein; William Gooding; James D Luketich; Tony E Godfrey; Steven J Hughes
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

Review 2.  High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis.

Authors:  HeLi Gao; Mei Guan; Zhao Sun; ChunMei Bai
Journal:  Tumour Biol       Date:  2015-01-31

3.  Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis.

Authors:  K Fazekas; O Csuka; I Köves; E Rásó; J Tímár
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 4.  Comprehensive review of targeted therapy for colorectal cancer.

Authors:  Yuan-Hong Xie; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Signal Transduct Target Ther       Date:  2020-03-20

Review 5.  Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.

Authors:  David N O'Dwyer; Shanna L Ashley; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

6.  c-MET expression in colorectal adenomas and primary carcinomas with its corresponding metastases.

Authors:  Mariana Fathy Gayyed; Nehad M R Abd El-Maqsoud; Amr Abd El-Hameed El-Heeny; Mostafa Fuad Mohammed
Journal:  J Gastrointest Oncol       Date:  2015-12

7.  Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats.

Authors:  Pius Maliakal; Maen Abdelrahim; Umesh T Sankpal; Cima Maliakal; Cheryl H Baker; Stephen Safe; Luis J Herrera; Ala Abudayyeh; Sumanth Kaja; Riyaz Basha
Journal:  Invest New Drugs       Date:  2011-01-04       Impact factor: 3.850

8.  Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver.

Authors:  Yu Zhang; Celestia Davis; James Ryan; Cory Janney; Maria Marjorette O Peña
Journal:  Clin Exp Metastasis       Date:  2013-06-09       Impact factor: 5.150

9.  NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells.

Authors:  Takeshi Kubota; Hiroaki Taiyoh; Atsushi Matsumura; Yasutoshi Murayama; Daisuke Ichikawa; Kazuma Okamoto; Hitoshi Fujiwara; Hisashi Ikoma; Masayoshi Nakanishi; Shojiro Kikuchi; Chouhei Sakakura; Toshiya Ochiai; Yukihito Kokuba; Hiroki Taniguchi; Teruhisa Sonoyama; Kunio Matsumoto; Toshikazu Nakamura; Eigo Otsuji
Journal:  Clin Exp Metastasis       Date:  2009-02-21       Impact factor: 5.150

10.  Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.

Authors:  G Sonvilla; S Allerstorfer; C Heinzle; S Stättner; J Karner; M Klimpfinger; F Wrba; H Fischer; C Gauglhofer; S Spiegl-Kreinecker; B Grasl-Kraupp; K Holzmann; M Grusch; W Berger; B Marian
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.